| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 46.083 | 38.271 | 49.384 | 48.703 | 51.922 | 52.372 | 56.933 |
| Total Income - EUR | - | - | - | 46.083 | 41.222 | 49.384 | 48.703 | 51.922 | 52.372 | 56.933 |
| Total Expenses - EUR | - | - | - | 46.233 | 37.375 | 42.895 | 43.506 | 47.622 | 48.898 | 52.991 |
| Gross Profit/Loss - EUR | - | - | - | -150 | 3.847 | 6.488 | 5.197 | 4.300 | 3.474 | 3.942 |
| Net Profit/Loss - EUR | - | - | - | -609 | 3.435 | 6.159 | 4.805 | 3.858 | 2.992 | 3.440 |
| Employees | - | - | - | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Steramicris S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 67 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 7.592 | 7.661 | 9.670 | 14.142 | 13.823 | 13.730 | 17.204 |
| Inventories | - | - | - | 6.664 | 6.517 | 7.968 | 7.561 | 7.926 | 8.807 | 9.214 |
| Receivables | - | - | - | 279 | 274 | 269 | 303 | 304 | 303 | 302 |
| Cash | - | - | - | 648 | 870 | 1.434 | 6.278 | 5.593 | 4.620 | 7.688 |
| Shareholders Funds | - | - | - | -623 | 2.824 | 8.930 | 13.537 | 13.169 | 12.886 | 16.255 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 8.281 | 4.837 | 740 | 605 | 654 | 844 | 949 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4712 - 4712" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Steramicris S.r.l.